Skip to main content
IC
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
67.74
+1.97 (3.00%)
At close: May 12, 2025, 4:00 PM
67.40
-0.34 (-0.50%)
After-hours: May 12, 2025, 7:16 PM EDT

Novo Nordisk Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
211.73B 206.62B 198.11B 192.75B 182.45B 173.47B 161.15B 154.71B
Diabetes Growth
16.05% 19.11% 22.93% 24.59% 23.92% 24.31% 21.21% 23.23%
Obesity
72.54B 65.15B 54.97B 48.42B 44.83B 41.63B 35.89B 27.97B
Obesity Growth
61.82% 56.48% 53.16% 73.14% 110.41% 146.87% 159.42% 134.98%
Rare Disease
18.87B 18.64B 17.51B 16.83B 16.97B 17.16B 17.45B 18.65B
Rare Disease Growth
11.21% 8.60% 0.34% -9.75% -14.09% -16.45% -14.49% -5.81%

Operating Income by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
134.75B 127.72B 117.71B 110.96B 106.68B 99.62B 90.58B 82.01B
Diabetes and Obesity Care Growth
26.31% 28.20% 29.95% 35.29% 41.90% 47.82% 45.45% 43.47%
Rare Disease
536.00M 620.00M 661.00M 504.00M 2.74B 2.95B 2.32B 4.15B
Rare Disease Growth
-80.40% -78.99% -71.50% -87.86% -50.18% -60.20% -74.47% -55.13%

Revenue by Geography
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
183.21B 178.17B 165.43B 157.88B 146.61B 136.63B 120.67B 109.37B
North America Growth
24.96% 30.41% 37.09% 44.35% 46.01% 49.97% 42.69% 40.05%
International
119.93B 112.23B 105.15B 100.12B 97.63B 95.63B 93.82B 91.95B
International Growth
22.84% 17.36% 12.08% 8.89% 11.10% 11.40% 13.54% 16.16%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.